Product Information
CETIRIZINE HCL 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0629 per EA under NDC 16571040210. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 26, 2009.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571040210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077829FDA Approved
8/26/2009
On Market Since
10/1/2009
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 10 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 20.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0629 per EA |
|---|---|
| All-time high | $0.0985 (Feb 12, 2014) |
| All-time low | $0.0539 (Jul 17, 2024) |
| 52-week high | $0.0721 |
| 52-week low | $0.0611 |
| Median price | $0.0703 |
| Average price | $0.0725 |
| Largest weekly change | +28.3% (Jun 17, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0629 per EA (NDC 16571040210), effective Aug 19, 2026.
How has the price of CETIRIZINE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 10 MG TABLET has declined 20.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 10 MG TABLET?
Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 10 MG TABLET has ranged from a low of $0.0539 (Jul 17, 2024) to a high of $0.0985 (Feb 12, 2014), with a median of $0.0703 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 10 MG TABLET?
16 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CETIRIZINE HCL 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CETIRIZINE HCL 10 MG TABLET?
CETIRIZINE HCL 10 MG TABLET (NDC 16571040210) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.